The Structure-Based Molecular-Docking Screen Against Core Clock Proteins to Identify Small Molecules to Modulate the...

Area of Science:

• Biochemistry
• Chronobiology
• Pharmacology

Background:

• Circadian rhythms govern daily physiological and biochemical processes.
• Disruptions to the circadian clock are linked to increased disease susceptibility.
• Targeting circadian rhythm pathways offers therapeutic potential.

Purpose of the Study:

• To describe virtual screening methods for identifying small molecules that modulate circadian clock protein activity.
• To focus on the core clock protein Cryptochrome 1 (CRY1) as a potential drug target.

Main Methods:

• Utilizing crystal structures of core clock proteins for structure-based drug design.
• Employing virtual screening techniques to computationally identify potential drug candidates.
• Focusing on Cryptochrome 1 (CRY1) as the target protein.

Main Results:

• The study outlines a virtual screening strategy applicable to CRY1.
• This approach facilitates the identification of small molecules that can regulate CRY1 activity.
• The described methods are amenable to high-throughput screening.

Conclusions:

• Virtual screening, particularly structure-based drug design, is a viable strategy for discovering circadian rhythm modulators.
• Targeting Cryptochrome 1 (CRY1) offers a promising avenue for developing therapeutics that address circadian rhythm disruptions.
• This work contributes to the development of novel approaches for drug discovery in chronobiology.